Artificial intelligence for aging research in cancer drug development
A new editorial paper was published in Aging, entitled, "Artificial intelligence for aging research in cancer drug development."
Dec 7, 2023
0
0
A new editorial paper was published in Aging, entitled, "Artificial intelligence for aging research in cancer drug development."
Dec 7, 2023
0
0
A new research paper was published in Aging, titled, "Contribution of membrane raft redox signaling to visfatin-induced inflammasome activation and podocyte injury."
Dec 5, 2023
0
9
In a recent study, scientists led by Professor Stefan Müller from Goethe University's Institute of Biochemistry II investigated a specific form of blood cancer known as acute myeloid leukemia, or AML. The disease mainly ...
Dec 4, 2023
0
15
In a study published in the journal Genes & Diseases, scientists from Union Hospital, Tongji Medical College, and Huazhong University of Science and Technology delve into the molecular intricacies of osteosarcoma in the elderly. ...
Dec 4, 2023
0
0
A new research paper was published on the cover of Aging titled, "Chronological aging impacts abundance, function and microRNA content of extracellular vesicles produced by human epidermal keratinocytes."
Nov 30, 2023
0
0
Insights that pave the way for novel therapeutic approaches to tackle cancer, fibrosis, and many age-related conditions have been uncovered by a team of scientists, including researchers from UCL.
Nov 29, 2023
0
18
The strangely named hedgehog pathway that's crucial to bone growth has emerged as a key in the fight to treat the bone cancer osteosarcoma.
Nov 28, 2023
0
1
A new research paper titled "1,5-anhydro-D-fructose induces anti-aging effects on aging-associated brain diseases by increasing 5'-adenosine monophosphate-activated protein kinase activity via the peroxisome proliferator-activated ...
Nov 28, 2023
0
0
Across the entire animal kingdom, visual images are processed by two major neuronal pathways that extract light and dark stimuli from visual scenes—ON (light on) and OFF (light off) pathways.
Nov 28, 2023
0
0
A study conducted at the University of Turku, Finland, shows that plixorafenib, a new drug developed for treating melanoma and lung cancer, may also stop the progression of cutaneous squamous cell carcinoma.
Nov 22, 2023
0
56